Research and experimental development on natural sciences and engineering
LUZMON MEDICAL AS
Revenue 2024
NOK 1.6m
Operating profit
NOK −5.7m
Equity
NOK 74.9m
Incorporated
2010
Share capital
NOK 2.0m
Key figures · 2024
Current ratio
20.95
Equity ratio
97.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -355.2% | |
| Net margin (%%) | 4.5% | |
| Return on assets (%%) | -7.4% | |
| Likviditet | ||
| Current ratio | 20.95 | |
| Working capital | 36.1m | |
| Soliditet | ||
| Equity ratio (%%) | 97.6% | |
| Debt-to-equity ratio | 0.02 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.